GARABED EKNOYAN to Follow-Up Studies
This is a "connection" page, showing publications GARABED EKNOYAN has written about Follow-Up Studies.
Connection Strength
0.113
-
Obesity and chronic kidney disease. Nefrologia. 2011; 31(4):397-403.
Score: 0.046
-
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006 Feb; 17(2):546-55.
Score: 0.031
-
Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis. Nephrol Dial Transplant. 2012 Feb; 27(2):640-6.
Score: 0.011
-
Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2008 Jan; 3(1):69-77.
Score: 0.009
-
Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2006 Apr; 47(4):614-24.
Score: 0.008
-
Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias". J Am Soc Nephrol. 2005 Nov; 16(11):3371-80.
Score: 0.008